The Effect of Liquid Meal Replacements on Cardiometabolic Risk Factors in Overweight/Obese Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Open accessPublished version of a preprint
The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The evidence for liquid meal replacements in diabetes has not been summarized. Our objective was to synthesize the evidence of the effect of liquid meal replacements on cardiometabolic risk factors in overweight/obese individuals with type 2 diabetes. RESEARCH DESIGN AND METHODS: Data sources included MEDLINE, EMBASE, and the Cochrane Library through 10 December 2018. We included randomized trials of ≥2 weeks assessing the effect of liquid meal replacements in weight loss diets compared with traditional weight loss diets on cardiometabolic risk factors in overweight/obese subjects with type 2 diabetes. Two independent reviewers extracted relevant data and assessed risk of bias. Data were pooled using the inverse variance method. The overall certainty of the evidence was evaluated using GRADE (Grading of Recommendations Assessment, Development and Evaluation). RESULTS: Nine trial comparisons (N = 961 [median follow-up 24 weeks]) met eligibility criteria. Mean differences were for body weight −2.37 kg (95% CI −3.30 to −1.44), BMI −0.87 kg/m2 (−1.31 to −0.42), body fat −1.66% (−2.17 to −1.15), waist circumference −2.24 cm (−3.72 to −0.77), HbA1c −0.43% (−0.66 to −0.19) (−4.7 mmol/mol [−7.2 to −2.1]), fasting glucose −0.63 mmol/L (−0.99 to −0.27), fasting insulin −11.83 pmol/L (−23.11 to −0.54), systolic blood pressure −4.97mmHg (−7.32 to −2.62), and diastolic blood pressure −1.98 mmHg (−3.05 to −0.91). There was no effect on blood lipids. The overall certainty of the evidence was low to moderate owing to imprecision and/or inconsistency. CONCLUSIONS: Liquid meal replacements in weight loss diets lead to modest reductions in body weight, BMI, and systolic blood pressure, and reductions of marginal clinical significance in body fat, waist circumference, HbA1c, fasting glucose, fasting insulin, and diastolic blood pressure. More high-quality trials are needed to improve the certainty in our estimates.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite these recommendations, less intense exercise and walking programs can reduce risk of DM.846,855”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [855]
In the citing paper
“For example, studies have consistently shown that a walking program is associated with reductions in DM incidence,855 and low-intensity exercise can improve glycemic control in T2D.939,940”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [855]
In the citing paper
“Only seven meta-analyses (LCDs, n = 5 [37–40, 41]; liquid meal replacement, n = 1 [42]; very low energy diet (VLED), n = 1 [43]) were assessed as high quality.”
In the citing paper
“One high-quality meta-analysis [42] of nine RCTs including 931 participants reported that replacing one to three main meals daily (replacing 13–47% of total energy) produced significantly greater weight loss than low-energy diets over 12–52 weeks (−2.4 kg; 95% CI −3.3, −1.4; I2 = 84%, p < 0.001; GRADE moderate certainty of evidence).”
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099 · cited 1×
“pected, Duval and Tweedie nonparametric “trim and fill” analyses were applied to assess the effect of the imputed “missing” studies (14).”
MethodTuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
The Look AHEAD Research Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212914 · Cited by 2,908
Meta-analyses involving cross-over trials: methodological issues
Elbourne, D. R., Altman, D. G., Higgins, J. P., Curtin, F., Worthington, H. V., & Vail, A. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.140 · Cited by 2,305
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095
Beneficial health effects of modest weight loss.
Dj, G. (1992) · PubMed · Cited by 1,263
Medicare's search for effective obesity treatments: Diets are not the answer.
Mann, T., Tomiyama, A. J., Westling, E., Lew, A.-M., Samuels, B., & Chatman, J. (2007) · American Psychologist · doi:10.1037/0003-066x.62.3.220 · Cited by 1,208 · cited 1×
“achieved by restricting food intake in the short-term, weight is typically regained over the long-term (39).”
BackgroundEffects of weight reduction on blood lipids and lipoproteins: a meta-analysis
Dattilo, A., & Kris-Etherton, P. (1992) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/56.2.320 · Cited by 1,055
Comparison of Weight Loss Among Named Diet Programs in Overweight and Obese Adults: A Meta-analysis
Johnston, B. C., Kanters, S., Bandayrel, K., Wu, P., Naji, F., Siemieniuk, R. A., Ball, G. D. C., Busse, J. W., Thorlund, K., Guyatt, G., et al. (2014) · JAMA · doi:10.1001/jama.2014.10397 · Cited by 704 · cited 1×
“popular weight loss programs of varying macronutrient compositions including the vegetarian diet, DASH (Dietary Approaches to Stop Hypertension) diet, Atkins diet, Weight Watchers diet, and the Zone diet have been shown to be of benefit in overweight/obese individuals with type 2 diabetes (8,16).”
BackgroundWeight management using a meal replacement strategy: meta and pooling analysis from six studies.
Heymsfield, S. B., van Mierlo, C. A. J., van der Knaap, H. C. M., Heo, M., & Frier, H. I. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802258 · Cited by 557
The evidence for the effectiveness of medical nutrition therapy in diabetes management
Pastors, J. G., Warshaw, H., Daly, A., Franz, M., & Kulkarni, K. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.608 · Cited by 434
Diabetes UK evidence‐based nutrition guidelines for the prevention and management of diabetes
Dyson, P. A., Twenefour, D., Breen, C., Duncan, A., Elvin, E., Goff, L., Hill, A., Kalsi, P., Marsland, N., McArdle, P., et al. (2018) · Diabetic Medicine · doi:10.1111/dme.13603 · Cited by 410 · cited 1×
“international diabetes guidelines have recommended a modest weight loss of 5–10% to improve glycemic control and other cardiovascular risk factors (7,9,32,37).”
BackgroundWeight Management in Type 2 Diabetes: Current and Emerging Approaches to Treatment
Van Gaal, L., & Scheen, A. (2015) · Diabetes Care · doi:10.2337/dc14-1630 · Cited by 221
Sievenpiper, J. L., Chan, C. B., Dworatzek, P. D., Freeze, C., & Williams, S. L. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.009 · Cited by 200
Self-citationType ii diabetic subjects lose less weight than their overweight nondiabetic spouses
Wing, R. R., Marcus, M. D., Epstein, L. H., & Salata, R. (1987) · Diabetes Care · doi:10.2337/diacare.10.5.563 · Cited by 190 · cited 1×
“However, overweight/obese individuals with type 2 diabetes tend to have greater difficulty losing weight and are at a greater risk for developing complications compared with overweight/ obese individuals without type 2 diabetes (32,38).”
BackgroundLi, Z., Hong, K. M., Saltsman, P., DeShields, S., Bellman, M., Thames, G., Liu, Y., Wang, H., Elashoff, R. M., & Heber, D. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602089 · Cited by 154 · cited 2×
“(20) partially explained the substantial heterogeneity for LDL-c (I(2) = 37%, PQ = 0.”
BackgroundOnline Statistics Education: A Multimedia Course of Study
Lane, D. M. (2003) · BiblioBoard Library Catalog (Open Research Library) · Cited by 132
Lifestyle Intervention: Results of the Treatment of Mild Hypertension Study (TOMHS)
Elmer, P. J., Grimm, R. A., Laing, B., Grandits, G. A., Svendsen, K. H., VanHeel, N., Betz, E., Raines, J., Link, M., Stamler, J., et al. (1995) · Preventive Medicine · doi:10.1006/pmed.1995.1062 · Cited by 132
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s007 · Cited by 117
Cheskin, L. J., Mitchell, A. M., Jhaveri, A. D., Mitola, A. H., Davis, L. M., Lewis, R. A., Yep, M. A., & Lycan, T. W. (2008) · The Diabetes Educator · doi:10.1177/0145721707312463 · Cited by 106
Liquid Meal Replacements and Glycemic Control in Obese Type 2 Diabetes Patients
Yip, I., Go, V. L. W., DeShields, S., Saltsman, P., Bellman, M., Thames, G., Murray, S., Wang, H., Elashoff, R., & Heber, D. (2001) · Obesity Research · doi:10.1038/oby.2001.140 · Cited by 86 · cited 2×
“Supplementary Tables 6 and 7 show sensitivity analyses in which trials using non–diabetes-specific liquid meal replacements (19,20,23,24) were removed.”
BackgroundThe why WAIT program: Improving clinical outcomes through weight management in type 2 diabetes
Hamdy, O., & Carver, C. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0071-5 · Cited by 85
Toft, U. N., Kristoffersen, L. H., Aadahl, M., von Huth Smith, L., Pisinger, C., & Jorgensen, T. (2007) · The European Journal of Public Health · doi:10.1093/eurpub/ckl262 · Cited by 79
Sun, J., Wang, Y., Chen, X., Chen, Y., Feng, Y., Zhang, X., Pan, Y., Hu, T., Xu, J., Lu-yuan, D., et al. (2008) · PubMed · Cited by 74
Wharton, S., Sharma, A. M., & Lau, D. C. W. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.025 · Cited by 54
Chee, W. S. S., Gilcharan Singh, H. K., Hamdy, O., Mechanick, J. I., Lee, V. K. M., Barua, A., Mohd Ali, S. Z., & Hussein, Z. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000384 · Cited by 48 · cited 2×
“seling versus UC) (26) led to substantial”
BackgroundStenvers, D. J., Schouten, L. J., Jurgens, J., Endert, E., Kalsbeek, A., Fliers, E., & Bisschop, P. H. L. T. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514001123 · Cited by 42 · cited 3×
“(25) for waist circumference and Keogh and Clifton (23) for systolic blood pressure explained all of the substantial heterogeneity (I(2) = 0%, PQ = 0.”
BackgroundThe challenge of managing coexistent type 2 diabetes and obesity
Bailey, C. J. (2011) · BMJ · doi:10.1136/bmj.d1996 · Cited by 36 · cited 1×
“, sulfonylureas, meglitinides, and thiazolidinediones) (6).”
Shirai, K., Saiki, A., Oikawa, S., Teramoto, T., Yamada, N., Ishibashi, S., Tada, N., Miyazaki, S., Inoue, I., Murano, S., et al. (2012) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2012.03.002 · Cited by 35 · cited 2×
“(24) changed the evidence for fasting insulin from significant to nonsignificant (P .”
BackgroundWeight Management Using a Meal Replacement Strategy in Type 2 Diabetes
Hamdy, O., & Zwiefelhofer, D. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0103-9 · Cited by 34
Meal Replacements for Weight Loss in Type 2 Diabetes in a Community Setting
Keogh, J. B., & Clifton, P. M. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/918571 · Cited by 23
Influenza, Pneumococcal, Hepatitis B and Herpes Zoster Vaccinations
Husein, N., & Chetty, A. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.016 · Cited by 15
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Evidence-based European recommendations for the dietary management of diabetes
The Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD), Aas, A.-M., Axelsen, M., Churuangsuk, C., Hermansen, K., Kendall, C. W. C., Kahleova, H., Khan, T., Lean, M. E. J., Mann, J. I., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05894-8 · Cited by 262
“Recommendations for food-based approaches are supported by systematic reviews and meta-analyses commissioned by the DNSG that included broader populations inclusive of those with diabetes or at risk for diabetes [70, 129, 130] as well as broader evidence on these foods and relevant outcomes [85, 131–136].”
InfluentialSelf-citationDietary interventions for obesity: clinical and mechanistic findings.
Chao, A. M., Quigley, K. M., & Wadden, T. A. (2021) · Journal of Clinical Investigation · doi:10.1172/jci140065 · Cited by 257
Churuangsuk, C., Hall, J., Reynolds, A., Griffin, S. J., Combet, E., & Lean, M. E. J. (2022) · Diabetologia · doi:10.1007/s00125-021-05577-2 · Cited by 204
“Only seven meta-analyses (LCDs, n = 5 [37–40, 41]; liquid meal replacement, n = 1 [42]; very low energy diet (VLED), n = 1 [43]) were assessed as high quality.”
BackgroundInfluentialSievenpiper, J. L. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuz082 · Cited by 144
Self-citation
Metadata
- Authors
- Noronha, J. C., Nishi, S. K., Braunstein, C. R., Khan, T. A., Blanco Mejia, S., Kendall, C. W. C., Kahleová, H., Rahelić, D., Salas-Salvadó, J., Leiter, L. A., & Sievenpiper, J. L.
- Affiliations
- St. Michael's Hospital (CA)
- Toronto 3D (Diet, Digestive Tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael’s Hospital, Toronto, Canada
- Physicians Committee for Responsible Medicine (US)
- University of Zagreb (HR)
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, Madrid, Spain
- Corresponding author
- Sievenpiper, John L.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2019-03-28
- Volume
- 42
- Issue
- 5
- Pages
- 767-776
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2923639533
- Cited by
- 65
- References
- 38
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 15 · 2023: 6 · 2022: 9 · 2021: 6 · 2020: 6 · 2019: 5
- FWCI
- 1.00
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- DNSG
- Canadian Institutes of Health Research (129920)
- Toronto 3D
- Physicians’ Services Incorporated Foundation
- Diabetes Canada
- Banting & Best Diabetes Centre
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Keywords
- type 2 diabetes, cardiometabolic risk factors, weight loss diet, overweight and obesity, weight loss, HbA1c, fasting insulin, blood pressure, waist circumference, fat mass, serum lipids, glycemic control, dietary intervention, body composition, fasting blood glucose, systolic blood pressure, diastolic blood pressure, body mass index
- MeSH terms
- Adult, Body Weight, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Diet, Reducing, Fasting, Female, Humans, Insulin, Male, Obesity, Risk Factors, Randomized Controlled Trials as Topic, Overweight, Meals
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.